-

CEUS Expert Asks: Does Your Dog Kiss You?

CHICAGO--(BUSINESS WIRE)--A medical ultrasound conference may be the last place physicians expected to be asked: Does your dog kiss you?

But that’s exactly the question asked Thursday during a presentation in Chicago on the benefit of using contrast enhanced ultrasound (CEUS) to resolve a range of medical problems including the identification of a tapeworm that is increasingly migrating from coyotes to dogs to humans, causing a potentially fatal liver mass.

Dr. Stephanie Wilson, a radiologist at the University of Calgary, said that CEUS was able to quickly identify the tapeworm-induced liver masses in four patients who were emergently sent to surgery and survived. Dr. Wilson spoke at the 38th annual Advances in Contrast Ultrasound conference and is co-president of the International Contrast Ultrasound Society.

“These masses are fortunately still rare but they require aggressive surgery, and conventional tests for the presence of tapeworm eggs can take many weeks,” she explained.

But we are so accustomed to using CEUS as a versatile and reliable problem-solving tool, so we naturally turned to CEUS when we encountered an upsurge of tapeworms in our area.”

Physicians more typically use ultrasound contrast agents to diagnose heart and vascular disease, identify and characterize tumors, monitor chronic gastro-intestinal diseases, evaluate other serious medical conditions and monitor therapy.

Unlike contrast agents used for MR or CT, ultrasound contrast agents do not contain dye, create no known risk of kidney damage or deposit of contrast media in the brain, and do not expose patients or hospital staff to ionizing radiation.

The conference in Chicago drew CEUS experts from North America, Europe, China, Japan, Israel and Brazil.

Ultrasound contrast agents are manufactured and sold by Bracco, Lantheus and GE Healthcare.

ABOUT ICUS:

The International Contrast Ultrasound Society (ICUS) is a nonprofit medical society dedicated to advancing the safe and medically appropriate use of contrast enhanced ultrasound (CEUS) to improve patient care globally. Membership in ICUS is available free of charge and there is no fee for ICUS CME-accredited educational programs, newsletters or other resources.

To join ICUS and learn more about CEUS, download ICUS Connect and visit the ICUS website (www.icus-society.org).

Contacts

International Contrast Ultrasound Society
Linda Maiman Feinstein, Advisor -- 847-624-1844 or 312-876-2563, Linda.Feinstein@Dentons.com
Robin J. Adams, Director of Communication -- 202-408-3946, Robin.Adams@Dentons.com

International Contrast Ultrasound Society


Release Summary
Does your dog kiss you? This was asked in a presentation on CEUS resolving medical problems including tapeworm causing a potentially fatal liver mass
Release Versions

Contacts

International Contrast Ultrasound Society
Linda Maiman Feinstein, Advisor -- 847-624-1844 or 312-876-2563, Linda.Feinstein@Dentons.com
Robin J. Adams, Director of Communication -- 202-408-3946, Robin.Adams@Dentons.com

More News From International Contrast Ultrasound Society

New Guidelines Support Safety and Benefits of Ultrasound-Enhancing Agents in Cardiology

CHICAGO & SÃO PAULO--(BUSINESS WIRE)--Contrast-enhanced ultrasound (CEUS) is “safe, cost-effective and widely-supported by scientific evidence,” according to new evidence-based guidelines on the use of microbubble contrast agents in cardiovascular ultrasound published by the Brazilian Society of Cardiology (DIC/SBC) with endorsement of the International Contrast Ultrasound Society (ICUS). The “Guideline on the Clinical Use of Ultrasound-Enhancing Agents in Cardiology Applications – 2026” suppor...

ICUS Files Landmark FDA Petitions Seeking Expanded Use of Contrast-Enhanced Ultrasound and Removal of Outdated “Black Box” Warnings

CHICAGO--(BUSINESS WIRE)--The International Contrast Ultrasound Society (ICUS) announced today that it filed two Citizen Petitions with the U.S. Food and Drug Administration (FDA) urging the agency to expand approved uses of contrast-enhanced ultrasound (CEUS) and to modernize its regulation. The first petition calls on the FDA to approve a whole-body indication for approved microbubble ultrasound contrast agents, replacing the traditional organ-by-organ approval approach. The second petition r...

ICUS Review Debunks Common Myth That “State Law” Bans Sonographer Administration of Ultrasound Contrast Agents

CHICAGO--(BUSINESS WIRE)--A comprehensive review of statutes and regulations across all 50 states and the District of Columbia challenges a common misconception that “state laws” prohibit trained and credentialed sonographers from placing intravenous (IV) lines and administering ultrasound contrast agents for contrast-enhanced ultrasound (CEUS) examinations, according to a new report released today by the International Contrast Ultrasound Society (ICUS).The report examines state laws and regulat...
Back to Newsroom